[Federal Register Volume 60, Number 80 (Wednesday, April 26, 1995)]
[Notices]
[Page 20476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10269]



 ========================================================================
 Notices
                                                 Federal Register
 ________________________________________________________________________
 
 This section of the FEDERAL REGISTER contains documents other than rules 
 or proposed rules that are applicable to the public. Notices of hearings 
 and investigations, committee meetings, agency decisions and rulings, 
 delegations of authority, filing of petitions and applications and agency 
 statements of organization and functions are examples of documents 
 appearing in this section.
 
 ========================================================================
 

  Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / 
Notices  
[[Page 20476]]

AGENCY FOR INTERNATIONAL DEVELOPMENT


Notice of Partially Closed Meeting

    Committee: Malaria Vaccine Program Advisory Committee.
    Date and Location: TvT Conference Room, 1601 North Kent Street, 
Suite 1104, Arlington, VA 22209.

1. April 27, 9 am-1 pm, (open session)
2. April 27, 1 pm-2:00 pm, (closed session)
3. April 27, 2 pm-5:00 pm, (open session)

    Agenda: The committee will (1) review progress towards malaria 
vaccine development by USAID-funded and other invited investigators and 
(2) review procurement actions, both current and planned. Closed 
Meeting: Portions of the meeting are closed under exemption 9(B) of 5 
U.S.C. 552(b) to discuss proposals, scopes of work, cost estimates, and 
other sensitive procurement information. Disclosures of such 
information would be likely to significantly frustrate implementation 
of current and futures procurement by USAID.

FOR FURTHER INFORMATION CONTACT: Steve Landry, Ph.D., Malaria Vaccine 
Development Program, USAID Office of Health and Nutrition, (SA-18 Room 
1238), Washington, DC 20523-1817, (703) 875-4508. John Tomaro, Chief, 
Environmental Health Division, Office of Health and Nutrition, Center 
for Population, Health and Nutrition, Bureau for Global Programs, Field 
Support and Research.

    Dated: April 21, 1995.
Mike Kitay,
Office of the General Counsel.

Charge to the Scientific Consultants Group

April 27, 1995.
    The Scientific Consultants Group (SCG) is charged with providing 
USAID with advice regarding its efforts to develop vaccines against 
malaria. During this meeting, the SCG is requested to make comments 
and recommendations in the following areas:

(1) The role of the SCG
(2) The MVDP progress on:
     MAP Initiative
     MSP-1 Initiatives
     MVDP Primate Program
     Field Studies in Kenya
(3) The appropriateness of MVDP plans for new activities:
     SERA Initiative
     AMA-1 Initiative
(4) The MVDP processes for selecting and developing new antigens
(5) The coordination among USAID/TDR/CEC
(6) The projected future scope and direction of the MVDP

USAID-Malaria Vaccine Development Program, Meeting of the Scientific 
Consultants Group

April 27, 1995.

9:00 a.m. to 5 p.m.

     Welcome--Representative of the Office of Health and 
Nutrition.
     Announcements/Introductions--Dr. Steve Landry.
     Review of Agenda--Dr. Steve Landry/Dr. Robin Powell.
     Approval of Winter '94 Minutes--Dr. Robin Powell/SCG 
Members.
     Review of the Role of the SCG--Dr. Steve Landry/Dr. 
Robin Powell.
     Discussion and Comment--SCG Members.
     Charge to the SCG--John Tomaro/Dr. Robin Powell.

Coffee Break

     MVDP Update.

Current Initiatives-Overview--Dr. Steve Landry
    MAP Initiative--Dr. Carter Diggs
    MSP-1 Initiatives--Dr. Carter Diggs
    MVDP Primate Program--Dr. Steve Landry
    Field Studies in Kenya--Dr. Steve Landry
Discussion and Comment--SCG Members

New Initiatives
    SERA Initiative--Dr. Carter Diggs
    AMA-1 Initiative--Dr. Carter Diggs
Discussion and Comment--SCG Members

Lunch

     MVDP process for selecting developing new antigens 
(closed session--Drs. Landry and Diggs.
     Discussion and Comment (closed session)--SCG Members.
     MVDP/TDR/CEC Coordination--Dr. Steve Landry.
     Discussion and Comment--SCG Members.
     Future directions/priorities for the MVDP--Drs. Landry 
and Diggs/SCG Members.
     Discussion and Comment--SCG Members.
     Deliberations, Conclusions and Recommendations--SCG 
Members.
     Debriefing--SCG/David Oot.
     Plans for the next meeting.

[FR Doc. 95-10269 Filed 4-25-95; 8:45 am]
BILLING CODE 6116-01-M